Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 51.69 | N/A |
| PEG Ratio (TTM) | -1.92 | N/A |
| P/S Ratio (TTM) | 0.53 | N/A |
| P/B Ratio (TTM) | 1.89 | N/A |
| P/FCF Ratio (TTM) | 13.07 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.75 | N/A |
| Price to 5YR AVG FCF Ratio | 67.90 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.44% | N/A |
| ROE (TTM) | 3.51% | N/A |
| Net Profit Margin (TTM) | 1.04% | N/A |
| ROIC 5YR AVG | 12.37% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 338.74% | 112.70% | 56.52% |
| Revenue | 7.34% | 44.49% | 34.34% |
| Net Income | 337.74% | 97.51% | 47.68% |
| Cash Flow | 196.86% | 117.71% | 129.58% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.49 | N/A |
| Quick Ratio (TTM) | 0.68 | N/A |
| D/E Ratio (TTM) | 0.93 | N/A |
| Interest Coverage (TTM) | 87.40 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.37 | N/A |
| LTL to 5YR AVG FCF | 29.06 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.66% | N/A |